glp-1 receptor agonist side effects Q&A: Understanding Benefits, Managing Adverse of Agonists negative side effects of glp-1

"Cardiovascular effects of incretin-based therapies: beyond glucose control." Peptides

Non-surgical treatments such as radiofrequency microneedling are effective for mild to moderate skin laxity but cannot replace surgery for patients with significant excess skin

While numerous proof-of-concept candidate molecules have been disclosed (3443), the only approved example of multi-receptor agonism for obesity and T2D is the dual GLP-1R/GIPR co-agonist tirzepatide (marketed as Mounjaro and Zepbound ) (34, 44)

A dermatologically tested and vegan formulation

doi:10.1016/j.surg.2008.12.008

Cost and limited insurance coverage are top barriers to access GLP-1 medications for obesity